Condition: Intracranial Arteriovenous Malformations · Sponsor: Ton-Bridge Medical Tech. Co., Ltd
The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.
This description comes directly from the study's public registry record.
Jing Pan · 18916099975 · jing.pan@ton-bridge.com
Jin Zheng
Always discuss trial participation with your own doctor first.
| Nanfang Hospital Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Zhujiang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | Active Not Recruiting |
| General Hospital of Eastern Theater Command | Nanjing, Jiangsu, China | Not Yet Recruiting |
| The First Hospital of Jilin University | Changchun, Jilin, China | Not Yet Recruiting |
| General Hospital of Northern Theater Command | Shenyang, Liaoning, China | Not Yet Recruiting |
| Qilu Hospital of Shandong University | Jinan, Shandong, China | Not Yet Recruiting |
| Xuanwu hospital Capital Medical University | Beijing, China | Recruiting |
| Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital | Chengdu, China | Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, China | Not Yet Recruiting |
| Anhui Provincial Hospital | Hefei, China | Not Yet Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06479343